학술논문
641P Phase I/II study of the EP4 antagonist CR6086 combined with the anti-PD-1 balstilimab in mismatch-repair-proficient and microsatellite stable (pMMR/MSS) chemorefractory metastatic colorectal cancer (mCRC)
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S452-S453
Subject
Language
ISSN
0923-7534